A review of co-processed directly compressible excipients

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 8, Issue 1, 2005, Pages 76-93

  Gohel, Mukesh C ^a   Jogani, Pranav D ^b  

^a L M COLLEGE OF PHARMACY   (India)

^b USV Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALPHA LACTOSE; ALUMINUM HYDROXIDE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; CELLULOSE DERIVATIVE; DEXTRIN; EMDEX; ETHYL CELLULOSE; EXCIPIENT; FILLER; GLUCOSE; HYDROXYPROPYLCELLULOSE; LACTITOL; LACTOSE; LUBRICATING AGENT; MALTODEXTRIN; MALTOSE; MANNITOL; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; STARCH; SUCROSE; SUGAR; XYLITOL;

BATCH PROCESS; DRUG FORMULATION; DRUG INDUSTRY; DRUG SOLUBILITY; GOOD MANUFACTURING PRACTICE; PARTICLE SIZE; REVIEW; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET MANUFACTURE;

COMPRESSIVE STRENGTH; EXCIPIENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 27444436820     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Review

References (120)

1. Sam, A. P., and Fokkens, J. G., Drug Delivery System: Adding Therapeutic and Economic Value to Pharmacotherapy. Part 2, Pharm. Tecb. Eur., 9: 58-66, 1997.
2. Rasenack, N., and Muller, B. W., Crystal Habit and Tableting Behaviour, Int. J. Pharm., 244: 45-57, 2002.
3. Khan, K. A. and Rhodes, C. T., The Production of Tablets by Direct Compression, Can. J. Pharm. Sci., 8:1-5, 1973.
4. Shangraw, R. F., Compressed Tablets by Direct Compression Granulation Pharmaceutical Dosage Forms: Tablets, Vol-1, Marcel Dekker, USA, 2nd ed, 195-246, 1989.
5. Shangraw, R. F., Direct Compression Tableting, Encyclopedia of Pharmaceutical Technology, Vol-4, Marcel Dekker, USA, 2nd ed., 85-160, 1988.
6. Shangraw, R. F., and Demarest, D. A., Survey of Current Practices in the Formulation and Manufacture of Tablets and Capsules, Pharm. Technol., 17: 32-44, 1993.
7. Robertson, M. L, Regulatory Issues with Excipients, Int. J. Pharm., 187: 273-276, 1999.
8. Silverstein, I., Excipient GMP Quality Standards One is Enough, Pharm. Technol, 25: 46-52, 2002
9. Armstrong, N. A., Functionality Related Tests for Excipients, Int. J. Pharm., 155: 1-5, 1997.
10. Banker, U. V., Role of Ingredients and Excipients in Developing Pharmaceuticals, Manuf Chem., 65: 32-34, 1994.
11. Reimerdes, D., The Near Future of Tablet Excipients, Manuf. Chem., 64:14-15, 1993.
12. Jivraj, M., Martini, L. G., and Thomson, C. M., An Overview of the Different Excipients Useful for the Direct Compression of Tablets, PSTT; 3: 58-63, 2000.
13. Armstrong, N. A., Selection of excipients for direct compression tablet formulation, Pharm. Technol. Eur., 9: 24-30, 1997.
14. Smewing, J., Powder flow analysis- the solution, Manuf Chem., 32-33, 2002.
15. Rubinstein, M H., Tablets Pharmaceutics: The Science of Dosage of Form, ChurchilL UK, 1st ed., 304-321, 1998.
16. Ibrahim, Y. K., and Olurinola, P. F., Comparative Microbial Contamination Levels in Wet Granulation and Direct Compression Methods of Tablet Production, Pharm. Acta. Helv., 66: 298-301, 1991.
17. Shangraw, R. F., Wallace, J. W., and Bowers, F. M., Morphology and Functionality in Tablet Excipients for Direct Compression, Pharm. Technol., 11: 136-143, 1987.
18. Bolhuis, G. K., and Chowhan, Z. T., Materials for Direct Compression, Pharmaceutical Powder Compaction Technology, Vol-7, Marcel Dekker, USA, 419-499, 1996
19. Russell, R., Synthetic Excipients Challenge All-Natural Organics -Offer advantages/ Challenges to Developers and Formulators, Pharm. Technol., 27: 38-50, 2004
20. Reimerdes, D., and Aufmuth, K. P., Tabletting with Co-processed Lactose-Cellulose Excipients, Manuf. Chem., 63: 21-24, 1992.
21. Puri, V., and Bansal, A., Pharmaceutical Technology: Challenges and Opportunities, Crips, 2: 2-11, 2001.
22. Product Information Brochure, Penwest, USA, 2000.
23. Product Information Brochure, SPI Polyols, France, 1999.
24. Joshi, V., Excipient choice in solid dosage forms, Drug. Del. Technol, 2: http://www.drugdelivery-tech.com/cgi-bin/articles.cgi?idArticle=69, 2002,
25. Antonio Moronim, A Novel Copovidone Binder for Dry Granulation and Direct-Compression Tableting, Pharm. Technol., 24: 8-12.
26. Guo, J., Lactose in Pharmaceutical Applications, Drug. Del. Technol., 4: http://www.drugdelivery-tech.com/cgi-bin/issues.cgi?idlssue=26, 2004.
27. Whiteman., M., and Yarwood., R. J., Evaluation of Six Lactose-Based Materials as Direct Compression Tablet Exciplents, Drug Dev. Ind. Pharm., 14: 1023-1040, 1988.
28. Lerk, C. F., Consolidation and Compaction of Lactose, Drug Dev. Ind. Pharm., 19: 2359-2398, 1993.
29. Molokhia, A. M., Al-Shora, H. L, and Hammad, A. A., Aging of Tablets Prepared by Direct Compression of Bases with Different Moisture Content, Drug Dev. Ind. Pharm., 13: 1933-1946, 1987.
30. Sebhatu, T., and Alderborn, G., Relationships Between the Effective Interparticulate Contact Area and the Tensile Strength of Tables of Amorphous and Crystalline Lactose of Varying Particle Size, Eur. J. Pharm. Sci., 8: 235-242, 1999.
31. Roberts, R. J., and Rowe, R. C., Effect of Punch Velocity On the Compaction of a Variety of Materials, J. Pharm. Pharmacol., 37: 377-384, 1985.
32. Fell, J. T., and Newton, J. M., The Tensile Strength of Tablets, J. Pharm. Sci., 20: 657-658, 1968.
33. Gohel, M. C., Patel, L. D., Murpani, D., and Iyer, L., Preparation of Directly Compressible Lactose and Optimization of Characteristics Affecting Direct Compression, Indian Drugs, 34: 322-326, 1997.
34. Gohel, M. C., Patel, L. D., Amin, A. F., Jogani, P. D., Bajaj, S. B., and Patel, G. J., Studies in Improvement of Flow and Compressional Characteristics of Lactose, Int. J. Pharm. Excip., 1: 86-92, 1999.
35. Michoel A, Rombaut P, Verhoye A., Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets, Pharm Dev Technol. 7:79-87, 2002.
36. Gohel, M. C., and Jogani, P. D., Functionality Testing of a Multifunctional Directly compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium, Pharm. Technol., 25, 64 -82, 2002.
37. Wong, D. Y., Wright, P., and Aulton, M. E., Defomation of Alpha-Lactose Monchydrate and Anhydrous Alpha-Lactose Monocrystals, Drug Dev. Ind. Pharm., 14: 2109-2126, 1988.
38. Van Kamp, H. V., Bolhuis, G. K., Kussendrager, K. D., and Lerk, C. F., Studies on Tableting Properties of Lactose IV, Dissolution and Disintegration Properties of Different Types of Crystalline Lactose, Int. J. Pharm., 28, 229-233, 1986.
39. Mendell, E. J., Direct Compression Method of Producing Solid Dosage Forms. Parts 1-3, Manuf Chem. Aero. News, 43: 47-49, 1972.
40. Shangraw, R. F., Wallace, J. W., and Bowers, F. M., Morphology and Functionality in Tablet Excipients for Direct Compression: Part 1, Pharm. Technol., 5: 69-78, 1981.
41. Steven, P., and Zimmerman, K., Lactose: the Natural Excipient, Manuf Chem., 57: 77-80, 1986.
42. Shukla, A. J., and Price, J. C., Effect of Moisture Content on Compression Properties of Directly Compressible High Beta-content Anhydrous Lactose, Drug Dev. Ind. Pharm., 17: 2067-2081, 1991.
43. Gunsel, W. C., and Lachman, L., Comparative Evaluation of Tablet Formulations Prepared from Conventionally processed and Spray-dried Lactose, J. Pharm. Sci., 52: 178-182, 1963.
44. Alpar, O., Hersey, J. A., and Shotton, E., The Compression. Properties of Lactose, J. Pharm. Pharmacol., 22: 1S-7S, 1970.
45. Khan, K. A., and Rhodes, C. T., Effect of Variation in Compaction Force on Properties of Six Direct Compression Tablet Formulation, J. Pharm. Sci., 65, 1835-1837, 1976.
46. Paronen, P., Behavior of Some Direct Compression Adjuvants During the Tableting Process, S.T.P. Pharma Pratiques., 2: 682-688, 1986.
47. Vromans, H., Bolhuis, G. K., Lerk, C. F., and Kussendrager, K. D., Studies on Tableting properties of Lactose VIII. The Effect of Variations in Primary Particle Size, Percentage of Amorphous Lactose and Addition of a Disintegrant on the Disintegration of Spray-dried Lactose Tablets, Int. J. Pharm., 39: 201-206, 1987.
48. Bolhuis, G. K., and Lerk, C. F., Comparative Evaluation of Excipients for Direct Compression. Part 1, Pharma. Weekb, 108: 469-481, 1973.
49. Bolhuis, G. K., and Zuurman, K., Tableting properties of Experimental and Commercially Available Lactose Granulations For Direct Compression, Drug Dev. Ind. Pharm., 21: 2057-2071, 1995.
50. Reier, G. E., and Shangraw, R. F., Microcrystalline Cellulose in Tableting, J. Pharm. Sci., 55: 510-514, 1966.
51. Dittgen, M., Microcrystalline Cellulose in Tableting, Manuf. Chem., 64: 17-21, 1993.
52. Lahdenpaa, E., Niskanen, M., and Yliruusi, J., Crushing Strength, Disintegration time and Weight Variation of Tablets Compressed from Three Avicel PH Grades and their Mixtures, Eur. J. Pharm. Biopharm., 43, 315-322, 1997.
53. Hwang, R., and Peck, G. R., A Systematic Evaluation of the Compression and Tablets Characteristics of Various Types of Microcrystalline Cellulose, Pharm. Technol, 24: 112-132, 2001.
54. Obae, K., Iijima, H., and Imada, K., Morphological Effect of Microcrystalline Cellulose Particles on Tablet Tensile Strength, Int. J. Pharm., 182: 155-164, 1999.
55. Mitrevej, A., Sinchaipanid, N., and Faroongsarng, D., Spray-Dried Rice Starch: Comparative Evaluation of Direct Compression Fillers, Drug Dev. Ind Pharm., 22: 587-594, 1996.
56. Pesonen, T., and Paronen, P, Evaluation of a New Cellulose Material as Binding Agent for Direct Compression of Tablets, Drug Dev. Ind. Pharm., 12: 2091-2111, 1986.
57. Tsai, T., Wu, J., Ho, H., and Sheu, M., Modification of physical characteristics of microcrystalline cellulose by codrying with β-cyclodextrin, J. Pharm. Sci, 87: 117-122, 1998.
58. Garr, J. S., Comparative Investigation of Novel Direct Compression Excipients, African J. Pharm. Pharma. Sci., 22: 250-256, 1992.
59. Reus-Medina, M., Lanz, M., Kumar, V., and Leuenberger, H., Comparative evaluation of the powder properties and compression behaviour of a new cellulose based direct compression excipient and Avicel PH 102, J. Pharm. Pharmacol. 56:, 951-956.
60. Levis, S.R., Deasy, P.B., Pharmaceutical applications of size reduced grades of surfactant co-processed microcrystalline cellulose, Int. J. Pharm., 230(1-2): 25-33, 2001.
61. Ishikawa, T., Mukai, B., Shiraishi, S., Utoguchi, N., Fujii, M., Mitsuo Matsumoto, and Watanaba, Y., Preparation of Rapidly Disintegrating Tablet Using New Types of Microcrystalline Cellulose (PH-M Series) and Low Substituted-Hydroxypropylcellulose or Spherical Sugar Granules by Direct Compresion Method, Chem. Pharm. Bull,. 49: 134 -139, 2001.
62. Lourdes Garzo'n, M., and Villafuerte, L., Compactibility of mixtures of calcium carbonate and microcrystalline cellulose, Int. J. Pharm., 231: 33 - 41, 2002.
63. Kothari, S. H., umar, V., and Banker, G. S., Comparative evaluations of powder and mechanical properties of low crystallinity celluloses, microcrystalline celluloses, and powdered celluloses, Int. J. Pharm., 232: 69-80, 2002.
64. Hasegawa, M., Direct Compression Microcrystalline Cellulose Grade 12 versus Classic Grade 102, Pharm. Technol, 25: 50-60, 2002.
65. Alvarez-Lorenzo, C. Gomez-Amoza J. L., Martinez-Pacheco, R., Souto C., and Concheiro, A., Evaluation of low-substituted hydroxypropylcelluloses as filler-binders for direct compression, Int. J. Pharm., 197(1-2): 107-116, 2000.
66. Crowley, M. M., Schroeder, B., Fredersdorf, A., Obara, S., Talarico, M., Kucera, S., and McGinity. J. W., Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion, Int. J. Pharm., 269 (2): 509-522, 2004.
67. Rizzuto, A. B., Chen, A. C., and Veiga, M. E., Modification of the Sucrose Crystal Structure to Enhance Pharmaceutical Properties of Excipient and Drug Substances, Pharm. Technol., 8: 32-39, 1984.
68. Bolhuis, G. K., Reichman, G., Lerk, C. F., Van Kamp, H. V., and Zuuarman, K., Evaluation of Anhydrous Alpha-Lactose, a New Excipient in Direct Compression, Drug Dev. Ind. Pharm., 11: 1657-1681, 1985.
69. Olmo, I. G., and Ghaly, E. S., Evaluation of Two Dextrose-Based Directly Compressible Excipients, Drug. Dev. Ind. Pharm., 24, 771-778, 1998.
70. Sangekar, S. A., Sarli, M., and Sheth, P. R., Effect of Moisture on Physical Characteristics of Tablets Prepared from Direct Compression Excipients, J. Pharm. Sci., 61: 939-944, 1972.
71. Mullick, S., Sa, B., and Bandyopadhyay, A. K., Development of Some New Direct-Compression Carriers from Indigenous Starches for Tablet Compression, Indian Drugs, 29: 676-679, 1992.
72. Sanghvi, P. P., Collins, C. C., and Shukla, A. J., Evaluation of Preflo Modified Starches as New Direct Compression Excipients-I: Tableting Characteristics, Pharm. Res., 10: 1597-1603, 1993.
73. Manudhane, K. S., Contractor, A. M., Kim, H. Y., and Shangraw, R. F., Tableting Properties of a Directly Compressible Starch, J. Pharm. Sci., 58: 616-620. 1969.
74. Heinze, F., Starch - the natural Excipient choice, Manuf. Chem., 40 - 42, 2002.
75. Monedero Perales, M. C., Munoz-Ruiz, A., Velasco Antequera, M. V., Munoz Munoz, N., and Jimenez-Castellanos, M. R., Comparative Tableting and Microstructural Properties of a New Starch for Direct Compression, Drug Dev. Ind. Pharm., 22: 689-695, 1996.
76. Hsu,, S. H., Tsai, T. R., Chuo, W. H., and Cham, T. M., Evaluation of Era-Tab as a Direct Compression Excipient, Drug Dev. Ind. Pharm., 23: 711-716, 1997.
77. Clausen, A. E., and Bernkop-Schnurch, A., Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery, J.Con. Rel., 75(1-2): 93-102, 2001.
78. Rees, J. E., and Rue, P. J., Time Dependent Deformation of Some Direct Compression Excipients, J. Pharm. Pharmacol., 30: 601-607, 1978.
79. Panaggio, A., Rhodes, C. T., and Schwartz, J. B., Properties of Mixtures of Two Tablet Matrices, Pharm. Acta Helv., 59: 37-39, 1984.
80. Schlack, H., Bauer-Brandl, A., Schuber, R., and Becker, D., Properties of Fujicalin®, a New Modified Anhydrous Dibasic Calcium Phosphate for Direct Compression: Comparison with Dicalcium Phosphate Dihydrate, Drug. Dev. Ind. Pharm., 27: 789-801, 2001.
81. Schüssele, A., and Bauer-Brand, A., Note on the measurement of flowability according to the European Pharmacopoeia, Int. J. Pharm., 257: 301-304, 2003.
82. Holte,O., Onsøyen, E., Myrvold, R., and Karlsen, K., Sustained release of water-soluble drug from directly compressed alginate tablets, Eur.J. Pharm. Sci., 20: 403-407, 2003.
83. Doldan, C., Souto, C., Concheiro, A., Martinez-Pacheco, R., and Gomez-Amoza, J. L., Dicalcium Phosphate Dihydrate and Anhydrous Dicalcium Phosphate for Direct Compression: Comparative study, Int. J. Pharm., 124: 69-74, 1995.
84. Eissens, A.C., Bolhuis, G.K., Hinrichs, W. L., and Frijlink, H.W., Inulin as filler-binder for tablets prepared by direct compaction, Eur. J. Pharm. Sci., 15: 31-38, 2002.
85. Eissens, A.C., Bolhuis, G.K., Adrichem, T. P., Wesselingh, J. A., and Frijlink, H.W., Hollow Filler-Binder as Excipients for Direct Compression, Pharm. Research, 20: 515-518, 2003.
86. Plaizier-Vercammen, J. A., and Van Den Bossche, H., Evaluation of the Tableting Properties of a New excipient for Direct Compression, Pharm. Ind, 54: 973-977, 1992.
87. Baykara, T., Duman, G., Ozesener, K. S., Ordu, S., and Ozates, B., Comparing the Compressibility of Ludipress with the other Direct Tabletting Agents by Using Acetaminophen as an Active Ingredient, Drug. Dev. Ind. Pharm., 17: 2359-2371, 1991.
88. Plaizier-Vercammen, J. A., and Van Den Bossche, H., Evaluation of the Tableting Properties of a New Excipient for Direct Compression, Drugs Made in Germany, 36: 133-137, 1993.
89. Schmidt, P. C., and Rubensdorfer, C. J., Evaluation of Ludipress as a Multipurpose Excipient for Direct Compression. Part 1. Powder Characteristics and Tableting Properties, Drug Dev. Ind Pharm., 20: 2899-2925, 1994.
90. Schmidt, P. C., and Rubensdorfer, C. J., Evaluation of Ludipress as a Multipurpose Excipient for Direct Compression Part II: Inactive Blending and Tableting with Micronized Glibeclamide, Drug Dev. Ind. Pharm., 20: 2927-2952, 1994.
91. Angel Munoz-Ruiz, M., Borrero-Rubio, J. M., and Jimenez-Castellanos, M. R., Rheology of a New Excipient for Direct Compression: Ludipress, Pharm. Acta. Helv., 67: 223-226, 1992.
92. Angel Munoz-Ruiz, M., Perales, C. M., Antequeva, V. V., and Villar, T., Rheology and Compression Characteristics of Lactose Based Direct Compression Excipients, Int. J. Pharm., 95: 201-207, 1993.
93. Monedero Perales, M. C., Munoz-Ruiz, A., Velasco Antequera, M. V., and Jimenez-Castellanos M. R., Study of the Compaction Mechanisms of Lactose-Based Direct Compression Excipients Using Indentation Hardness and Heckel plot, J. Pharm. Pharmacol, 46: 177-181, 1994.
94. Garr, J. S., and Rubinstein, M. H., Compaction Properties of a Cellulose-Lactose Direct Compression Excipient, Pharm. Tech. Int., 3: 24-27, 1991.
95. Armstrong, N. A., Roscheisen, G., and Al-Aghbar, M. R., Cellactose As a Tablet Diluent, Manuf. Chem., 67: 25-26, 1996.
96. Belda, P. M., and Mielck, J. B, The Tabletting Behaviour of Cellactose Compared With Mixtures of Celluloses with Lactoses, Eur. J. Pharm. Biopharm., 42: 325-330, 1996.
97. Casalderrey, M., Souto, C., Concheiro, A., Gomea-Amoza, J. L., and Martinez-Pacheco, R., A Comparison of Cellactose with Two Ad hoc Processed Lactose-Cellulose Blends as Direct Compression Excipients, Chem. Pharm. Bull., 48: 458-463, 2000.
98. Gohel, M. C., and Jogani, P. D., An Investigation of the Direct Compression Characteristics of Co-processed Lactose Microcrystalline Cellulose Using Statistical Design, Pharm. Technol., 22: 54-62, 1999.
99. Gohel, M. C., Modi, C. J., and Jogani, P. D., Functionality Testing of a Co-processed Diluent Containing Lactose and Microcrystalline Cellulose, Pharm. Technol, 22: 40-46, 1999.
100. Gohel, M. C., and Jogani, P. D., Exploration of Melt Granulation Technique for the Development of Co-processed Directly Compressible Adjuvant Containing Lactose and Microcrystalline Cellulose, Pharm. Dev. Tech., 8: 175-185, 2003.
101. Gohel, M. C., Bariya, S., and Jogani, P. D., Investigation in Direct Compression Characteristics of Co-processed Adjuvant Containing Lactose, Microcrystalline cellulose and Dicalcium Phosphate, Pharm. Dev. Tech., 8: 143-152, 2003.
102. Luukkonen, P., Schaefer, T., Hellen, L., Juppo, A. M., and Yliruusi, J., Rheological Characterization of Microcrystalline Cellulose and Silicified Microcrystalline Cellulose Wet Masses Using a Mixer Torque Rheometer, Int. J. Pharm., 188: 181-192, 1999.
103. Allen, J. D., Improving DC with SMCC, Manuf. Chem., 67: 19-20& 23, 1996.
104. Fraser, S. D., Michael, T., Stephan, E., Ansong, C., Staniforth, J. N., Physicochemical and Mechanical Evaluation of a Novel high Density Grade of Silicified Microcrystalline Cellulose, Drug Dev. Ind. Pharm., 30: 103-109, 2004.
105. Lahdenpaa, E., Antikainen, O., and Yliruusi, J., Direct Compression with Silicified and Non-Silicified Microcrystalline Cellulose: Study of Some Properties of Powders and Tablets, S. T. P. Pharm. Sci., 11: 129-135, 2001.
106. Kachimanis, K., Nikolakakis, L, and Malamataris, S., J. Pharm Sci., 92: 1489-1501, 2003.
107. Bolhuis, G. K., Veen, B., Wu, Y. S., Zuuraman. K., and Frijlink, H. W., Compaction mechanism and tablet strength of unlubricated and lubricated silicified microcrystalline cellulose, Eur. J. Pharm. Biopharm., 59: 133-138, 2005.
108. Meggle AG, Technical information at www.meggle-pharma.de/en/product/uebersicht/starlac.
109. Hauschild, K., and Picker, K. M., Evaluation of a new co-processed compound based on lactose and maize starch for tablet formulation, http://www.aapspharmsci.org, AAPS Pharmasci, 6: Article 16, 2004.
110. Gohel, M. C., and Jogani, P. D., An Investigation in Direct Compression Characteristics of Co-processed Lactose-Starch using Experimental Design, Indian J. Pharm. Sci., 65: 31-38, 2003.
111. Kim, H., Venkatesh, G., and Fassihi, R., Compactibility Characterization of Granular Pectin for Tableting Operation Using a Compaction Simulator, Int. J. Pharm., 161: 149-159, 1998.
112. Niwa, T., Takeuchi, H., Hino, T., Itoh, A., and Kawashima, Y., and Kiuchi, K., Preparation of Agglomerated Crystals for Direct Tableting and Microencapsulation by the Spherical Crystallization Technique with a Continuous System, Pharm. Research, 11: 478-484, 1994.
113. Deodhar, U. P., Paradkar,, A. R., and Purohit, A. P., Preliminary Evaluation of Leucaena leucocephala Seed Gum as a Tablet Binder, Drug Dev, Ind. Pharm., 24: 577-582, 1998.
114. Kawashima, Y., Okumura, M., and Kojima, A., Direct Preparation of Spherically Agglomerated Salicylic Acid Crystal During Crystallization, J. Pharm Sci., 73: 1535-1538, 1984.
115. Lennartz, P., and Mielck, J. B., Minitableting: Improving the Compactibility of Paracetamol Powder Mixtures, Int. J. Pharm., 173: 75-85, 1998.
116. Zuuarman, K., Maarschalk, V., and Bolhuis, G. K., Effect of Magnesium Stearate on Bonding and Porosity Expansion of Tablets Produced from Materials with Different Consolidation Properties, Int. J. Pharm., 179: 107-115, 1999.
117. Holzer, A. W., and Sjogren, J., Evaluation of Some Lubricants by the Comparison of Friction Coefficients and Tablet Properties, Acta. Pharm. Suec, 18: 139-148, 1981.
118. Kuentz, M., Leurenberger, H., and Kolb, M., Fracture in Disordered Media and Tensile Strength of Microcrystalline Cellulose Tablets at Low Relative Densities, Int. J. Pharm., 182: 243-255, 1992.
119. Maarschalk, V., Zuurman, K., Vromans, H., Bolhuis, G. K., and Lerk, C. F., Porosity Expansion of Tablets as a Results of Bonding and Deformation of Particles Solids, Int. J. Pharm., 140: 185-193, 1996.
120. DeCrosta, M. T., Schwartz, J. B., Wigent, R. J., and Marshall, K., Thermodynamic Analysis of Compact Formation: Compaction, unloading and Ejection II, Int. Pharm., 213: 45-62,2001.